This, the latest issue of the International Journal of Urology, contains seven Original Articles and three Urological Notes. Of the seven Original Articles, three report the results of prospective randomized controlled trials. The first of these examines the need for placement of a double-J stent after ureteroscopy. Routine stenting is used in order to maintain the passage of urine and allow healing of the injured ureteral mucosa, but can be associated with irritation and pain that can impact on quality of life. Although this issue has been extensively discussed in the literature, the majority of previous studies were retrospective in design. In this context, Bach et al. (Herne, Germany) prospectively compared ureteral catheterization for 6 h versus double-J stent insertion for 5 days after stone extraction in terms of ureteral stent-related symptoms and pain assessed by a validated questionnaire. The second study addresses the significance of psychotherapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome. As readers might be aware, involvement of psychological factors has been suspected in the pathogenesis of this disease, and many researchers have studied the relationship between the two. To investigate this issue, Wang et al. (Taizhou, China) carried out a randomized controlled trial to compare routine medication alone with psychological intervention therapy combined with routine medication. They found that psychological intervention therapy was able to effectively improve the psychological status and sexual function in patients with category III chronic prostatitis/chronic pelvic pain syndrome in comparison with routine medication. The last study investigates the effect of antimuscarinics on prostatic size in patients with benign prostate enlargement and overactive bladder. Although combined therapy with antimuscarinics and an α-blocker ameliorated the symptoms more effectively than α-blocker alone, the mechanism by which antimuscarinics relieve such symptoms remains to be elucidated. In this setting, based on the results of a study suggesting that muscarinic acetylcholine receptors in the prostate are involved in prostatic growth and contraction, Sakalis et al. (Thessaloniki, Greece) investigated changes in morphometric prostate parameters (total prostate and adenoma volumes, prostate vascularity) before and after combination therapy with solifenacin and tamsulosin in comparison with tamsulosin monotherapy. They found that solifenacin decreases the total prostate and adenoma volume, as well as vascularity. Another Original Article by Kanao et al. (Aichi, Japan) describes the development of a novel biopsy instrument that extends the side-notch length to 25 mm and the stroke length to 28 mm. They found that this instrument with a 25-mm side-notch allows longer tissue samples to be obtained safely, allowing a significantly higher rate of prostate cancer detection by transrectal biopsy than a standard instrument with a 19-mm side-notch length. This might become a valuable modality for increasing the cancer detection rate and enhancing the diagnostic value of biopsy in addition to current strategies, such as increasing the number of cores, template-guided biopsy and magnetic resonance imaging–ultrasound fusion-guided biopsy. In a Urological Note, Ko et al. (Daegu, Korea) report a training curriculum using a robotic simulator for acquiring the required skills for robot-assisted surgery. Yano et al. (Saitama, Japan) found that, unlike monthly dosing with zoledronic acid, the primary addition of zoledronic acid every 3 months to primary androgen deprivation therapy in patients with bone metastatic prostate cancer has no favorable impact on prostate-specific antigen progression-free survival or skeletal-related event-free survival. Finally, based on analysis with a self-administered questionnaire, Sato et al. (Sapporo, Japan) report that shock wave lithotripsy has treatment outcomes comparable with those of ureteroscopic surgery, and significantly less severe treatment-related complaints. None declared.